abstract |
There is provided compounds of formula I: wherein the dotted lines, U5 V5 X1, Y, R1, R2 and R4 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of a member of the MAPEG family is desired and/or required, and particularly in the treatment of inflammation. |